pruritus
Showing NaN - NaN of 8
Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)
Completed
- Pruritus
- Atopic Dermatitis
- difelikefalin 0.25 mg
- +3 more
-
Anniston, Alabama
- +39 more
Mar 30, 2022
Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Birmingham, Alabama
- +48 more
May 18, 2021
Pruritus, Prurigo Nodularis, Atopic Dermatitis Trial in Worldwide (5 mg Serlopitant Tablets)
Terminated
- Pruritus
- +3 more
- 5 mg Serlopitant Tablets
-
Birmingham, Alabama
- +84 more
May 18, 2021
Pruritus, Atopic Dermatitis Trial in United States (Serlopitant High Dose, Placebo Oral Tablet, Serlopitant Low Dose)
Completed
- Pruritus
- Atopic Dermatitis
- Serlopitant High Dose
- +2 more
-
Anniston, Alabama
- +51 more
May 18, 2021
Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral
Completed
- Chronic Kidney Diseases
- Pruritus
- CR845 0.25 mg Oral Tablet
- +3 more
-
Birmingham, Alabama
- +59 more
Oct 22, 2020
Uremic Pruritus, Pruritus Trial in United States (nalbuphine HCl ER)
Completed
- Uremic Pruritus
- Pruritus
- nalbuphine HCl ER
-
Birmingham, Alabama
- +34 more
Aug 19, 2020
Uremic Pruritus, Pruritus Trial in Poland, Romania, United States (nalbuphine HCl ER tablets 60 mg BID, nalbuphine HCl ER
Completed
- Uremic Pruritus
- Pruritus
- nalbuphine HCl ER tablets 60 mg BID
- +2 more
-
Birmingham, Alabama
- +46 more
Aug 19, 2020
